Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2025)
Historic Times Interest Earned for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to -$4.13.
- Aquestive Therapeutics' Times Interest Earned fell 3851.79% to -$4.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.02, marking a year-over-year decrease of 15236.96%. This contributed to the annual value of -$2.77 for FY2024, which is 1609.35% down from last year.
- As of Q3 2025, Aquestive Therapeutics' Times Interest Earned stood at -$4.13, which was down 3851.79% from -$4.09 recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Times Interest Earned ranged from a high of $0.02 in Q2 2024 and a low of -$7.81 during Q2 2022
- For the 5-year period, Aquestive Therapeutics' Times Interest Earned averaged around -$4.04, with its median value being -$3.22 (2024).
- As far as peak fluctuations go, Aquestive Therapeutics' Times Interest Earned soared by 10064.56% in 2024, and later tumbled by 2075422.64% in 2025.
- Over the past 5 years, Aquestive Therapeutics' Times Interest Earned (Quarter) stood at -$6.69 in 2021, then grew by 2.96% to -$6.49 in 2022, then skyrocketed by 73.5% to -$1.72 in 2023, then tumbled by 183.98% to -$4.89 in 2024, then grew by 15.47% to -$4.13 in 2025.
- Its Times Interest Earned stands at -$4.13 for Q3 2025, versus -$4.09 for Q2 2025 and -$6.96 for Q1 2025.